Government: No cough syrup sale sans prescription

In a bid to regulate the sale of cough syrups, the Indian government has withdrawn a long-standing exemption that allowed certain syrup formulations to be sold without a prescription. This decision is likely to affect the way pharmaceutical companies manufacture and market their products, as well as how consumers purchase and use them. The government's move is aimed at ensuring that medicines are used responsibly and that their sale is strictly monitored. The new regulation is expected to come into effect soon, and it will require pharmacists to verify prescriptions before selling cough syrups to customers. This change is seen as a step towards promoting responsible use of medicines and preventing their misuse. The government has been working to strengthen the country's pharmaceutical regulatory framework, and this move is part of a broader effort to improve public health outcomes. The new rule will also help to prevent the diversion of cough syrups for illicit purposes, such as the manufacture of illicit drugs. Furthermore, it will enable the government to track the sale of cough syrups more effectively and prevent their sale to minors. The government's decision has been welcomed by healthcare experts, who believe that it will help to reduce the risks associated with the misuse of cough syrups. However, some consumers have expressed concerns about the potential inconvenience of having to obtain a prescription to purchase a commonly used medicine. The government has assured consumers that the new regulation will not lead to a shortage of cough syrups, and that they will still be widely available at pharmacies across the country. The regulation is also expected to have a positive impact on the pharmaceutical industry, as it will encourage companies to develop new and safer products. Additionally, the government plans to launch a public awareness campaign to educate consumers about the importance of using medicines responsibly and the need to follow proper prescribing guidelines.